Lamya Garabet

1.0k total citations · 1 hit paper
25 papers, 637 citations indexed

About

Lamya Garabet is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, Lamya Garabet has authored 25 papers receiving a total of 637 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 7 papers in Immunology and 5 papers in Genetics. Recurrent topics in Lamya Garabet's work include Platelet Disorders and Treatments (15 papers), Blood groups and transfusion (5 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (3 papers). Lamya Garabet is often cited by papers focused on Platelet Disorders and Treatments (15 papers), Blood groups and transfusion (5 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (3 papers). Lamya Garabet collaborates with scholars based in Norway, United States and Spain. Lamya Garabet's co-authors include Mimi Kim, Allen D. Sawitzke, Lisa R. Sammaritano, T. Flint Porter, Mary D. Stephenson, Jane E. Salmon, Joan T. Merrill, Michelle Petri, D. Ware Branch and Jill P. Buyon and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Annals of Internal Medicine.

In The Last Decade

Lamya Garabet

20 papers receiving 627 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Predictors of Pregnancy Outcomes in Patients With Lupus

2015 359 citations Jill P. Buyon, Mimi Kim et al. Annals of Internal Medicine profile →

Peers

Countries citing papers authored by Lamya Garabet

Since Specialization

Citations

This map shows the geographic impact of Lamya Garabet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lamya Garabet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lamya Garabet more than expected).

Fields of papers citing papers by Lamya Garabet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lamya Garabet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lamya Garabet. The network helps show where Lamya Garabet may publish in the future.

Co-authorship network of co-authors of Lamya Garabet

This figure shows the co-authorship network connecting the top 25 collaborators of Lamya Garabet. A scholar is included among the top collaborators of Lamya Garabet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lamya Garabet. Lamya Garabet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Immune thrombocytopenia: Modern management, knowledge gaps, and future perspectives 2025 ·Pure Amsterdam UMC ·Waleed Ghanima, Lamya Garabet, Rick Kapur, Drew Provan	0
2	Markers of refractory primary immune thrombocytopenia 2023 ·British Journal of Haematology ·Guillaume Moulis, Lamya Garabet	2
3	SARS-CoV-2 vaccines are not associated with hypercoagulability in apparently healthy people 2023 ·Research and Practice in Thrombosis and Haemostasis ·Lamya Garabet, Anna Eriksson, Eirik Tjønnfjord, (unknown), Magnus Kringstad Olsen, (unknown), (unknown), (unknown), Marie‐Christine Mowinckel, Maria Therese Ahlén, Ingvild Hausberg Sørvoll, (unknown), (unknown), (unknown), Benedicte Stavik, René Holst, Per Morten Sandset, Waleed Ghanima	3
4	Real-World Use, Effectiveness and Safety of Romiplostim, Eltrombopag and Avatrombopag in Immune Thrombocytopenia: Data from the Norwegian ITP Registry 2023 ·Blood ·(unknown), Lamya Garabet, (unknown), Eirik Tjønnfjord, Galina Tsykunova, (unknown), Hoa Tran, Mariasanta Napolitano, Waleed Ghanima	0
5	Evaluation of the diagnostic performance of three D-dimer assays in patients with suspected deep vein thrombosis: STA-Liatest D-Di plus, Tina-quant D-dimer Gen. 2, and INNOVANCE D-dimer 2023 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), (unknown), E. Amundsen, (unknown), (unknown), (unknown), Waleed Ghanima, Lamya Garabet	2
6	Complement activation negatively affects the platelet response to thrombopoietin receptor agonists in patients with immune thrombocytopenia: a prospective cohort study 2023 ·Platelets ·A Akesson, James B. Bussel, Myriam Martin, Anna M. Blom, Jenny Klintman, Waleed Ghanima, Eva Zetterberg, Lamya Garabet	8
7	Thromboembolic complications during and after hospitalization for COVID-19: Incidence, risk factors and thromboprophylaxis 2022 ·SHILAP Revista de lepidopterología ·Birgitte Tholin, (unknown), Anders Tveita, (unknown), (unknown), (unknown), (unknown), Lamya Garabet, Jamal Ahmed, Knut Stavem, Waleed Ghanima	4
8	β-Amyloid in Cerebrospinal Fluid: How to Keep It Floating (Not Sticking) by Standardization of Preanalytic Processes and Collection Tubes 2021 ·The Journal of Applied Laboratory Medicine ·(unknown), Lamya Garabet, Börje Bjelke, (unknown), (unknown), Morten K. Moe	5
9	Cytokine and Gene Expression Profiling in Patients with <b><i>HFE</i></b>-Associated Hereditary Hemochromatosis according to Genetic Profile 2020 ·Acta Haematologica ·(unknown), (unknown), (unknown), Lamya Garabet, (unknown), Morten K. Moe, Ole Kristoffer Olstad, Christine Monceyron Jonassen	3
10	PS1497 NEUTROPHIL EXTRACELLULAR TRAPS (NETS), BLOOD CELL COUNTS AND THROMBOTIC RISK IN ITP PATIENTS 2019 ·HemaSphere ·Marı́a Luisa Lozano, María Piedad Fernández-Pérez, (unknown), (unknown), Nuria García‐Barberá, Lamya Garabet, Waleed Ghanima, Constantino Martı́nez, Rocío Gónzález‐Conejero	1
11	Markers of endothelial cell activation and neutrophil extracellular traps are elevated in immune thrombocytopenia but are not enhanced by thrombopoietin receptor agonists 2019 ·Thrombosis Research ·Lamya Garabet, Carola E. Henriksson, Marı́a Luisa Lozano, Waleed Ghanima, James B. Bussel, Ellen Brodin, María Piedad Fernández-Pérez, Constantino Martı́nez, Rocío Gónzález‐Conejero, Marie‐Christine Mowinckel, Per Morten Sandset	29
12	Increased microvesicle-associated thrombin generation in patients with immune thrombocytopenia after initiation of thrombopoietin receptor agonists 2019 ·Platelets ·Lamya Garabet, Waleed Ghanima, Marit Hellum, Per Morten Sandset, James B. Bussel, Hoa Tran, Carola E. Henriksson	16
13	The Risk of Thromboembolism Associated with Treatment of ITP with Rituximab: Adverse Event Reported in Two Randomized Controlled Trials 2019 ·Blood ·Lamya Garabet, Pål André Holme, Bernadette Darné, Abderrahim Khélif, Tor Henrik Anderson Tvedt, Marc Michel, Waleed Ghanima	6
14	Circulating microRNAs in patients with immune thrombocytopenia before and after treatment with thrombopoietin-receptor agonists 2019 ·Platelets ·Lamya Garabet, Waleed Ghanima, Anbjørg Rangberg, Raúl Teruel‐Montoya, Constantino Martı́nez, Marı́a Luisa Lozano, (unknown), James B. Bussel, Per Morten Sandset, Christine Monceyron Jonassen	23
15	Antiphospholipid Antibodies are Associated with Low Levels of Complement C3 and C4 in Patients with Systemic Lupus Erythematosus 2016 ·Scandinavian Journal of Immunology ·Lamya Garabet, (unknown), Marie‐Christine Mowinckel, Anne Flem Jacobsen, Tom E. Mollnes, Per Morten Sandset, Eva‐Marie Jacobsen	10
16	Predictors of Pregnancy Outcomes in Patients With Lupus breakdown → 2015 ·Annals of Internal Medicine ·Jill P. Buyon, Mimi Kim, Marta Guerra, Carl A. Laskin, Michelle Petri, Michael D. Lockshin, Lisa R. Sammaritano, D. Ware Branch, T. Flint Porter, Allen D. Sawitzke, Joan T. Merrill, Mary D. Stephenson, (unknown), Lamya Garabet, Jane E. Salmon	359
17	Evaluation of OneTouch Verio, a new blood glucose self-monitoring system for patients with diabetes 2013 ·(unknown), (unknown), (unknown), (unknown), Snezana Djurisic, (unknown), Lamya Garabet, Eva Greibe, (unknown), Dorte Aalund Olsen, (unknown), (unknown), Johanna Westerlund	1
18	Prevalence of pulmonary hypertension in an unselected, mixed connective tissue disease cohort: results of a nationwide, Norwegian cross-sectional multicentre study and review of current literature 2013 ·Lara D. Veeken ·Ragnar Gunnarsson, (unknown), Øyvind Molberg, Åse Stavland Lexberg, (unknown), (unknown), (unknown), Øyvind Palm, (unknown), (unknown), (unknown), Villy Johnsen, Søren Pedersen, Anne Prøven, Lamya Garabet, T. Garen, Trond Mogens Aaløkken, I-M Gilboe, Jan Tore Gran	51
19	Evaluation of OneTouch Verio^®, a new blood glucose self-monitoring system for patients with diabetes 2013 ·Scandinavian Journal of Clinical and Laboratory Investigation ·Karin Littmann, (unknown), (unknown), (unknown), Snezana Djurisic, (unknown), Lamya Garabet, Eva Greibe, (unknown), Dorte Aalund Olsen, (unknown), (unknown), Johanna Westerlund	8
20	Prevalence and severity of interstitial lung disease in mixed connective tissue disease: a nationwide, cross-sectional study 2012 ·Annals of the Rheumatic Diseases ·Ragnar Gunnarsson, Trond Mogens Aaløkken, Øyvind Molberg, May Brit Lund, Georg Mynarek, Åse Stavland Lexberg, (unknown), (unknown), (unknown), Øyvind Palm, (unknown), Andrea Becker-Merok, (unknown), Villy Johnsen, (unknown), Anne Prøven, Lamya Garabet, Jan Tore Gran	69

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact